Work

0731 Cognitive and Functional Outcomes from the Phase 3 Open-Label Extension and Randomized-Withdrawal ENCORE Trial of AXS-12 in Narcolepsy with Cataplexy

Year: 2026

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0730

Authors: Bruce Corser, Michael Thorpy, Lois Krahn, Richard Bogan, Colin Shapiro, Dan Chen, Angad Chhabra, Herriot Tabuteau

Institutions: Albert Einstein College of Medicine, Mayo Clinic, University of South Carolina, Axsome Therapeutics (United States)

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160646545

Cites:

Cited by:

Related to: